Welcome to Kaplan's Lab

We study ciliopathies using C. elegans and bioinformatics to uncover the molecular basis of rare diseases.

Cilia Illustration

Our lab is dedicated to uncovering the genetic and molecular mechanisms driving rare diseases, with a particular focus on ciliopathies. By integrating comparative genomics, functional assays, and cutting-edge gene editing technologies, we aim to bridge the gap between genotype and phenotype, advancing our understanding of disease mechanisms and identifying potential therapeutic targets.

Research Updates

Research Icon

Turan MG, Kantarci H, Cevik S, Kaplan OI. ARL13B regulates juxtaposed cilia-cilia elongation in BBSome dependent manner in Caenorhabditis elegans. iScience. 2025 Jan 10;28(2):111791. doi: 10.1016/j.isci.2025.111791

Research Icon

Pir MS, Cevik S, Kaplan OI. CilioGenics: an integrated method and database for predicting novel ciliary genes. Nucleic Acids Res. 2024 Aug 12;52(14):8127-8145. doi: 10.1093/nar/gkae554

Research Icon

March 26, 2025: We recently identified a link between CILK1/DYF-5 and cranioectodermal dysplasia by integrating patient-derived cells and C. elegans models. Our study, titled "A homozygous frameshift variant in the CILK1 gene causes cranioectodermal dysplasia", has been submitted for publication.

Research Icon

March 2025: New publication in iScience on cilia-cilia elongation! Read more

Research Icon

January 2025: Kaplan Lab receives grant for ciliopathy research.